Company Filing History:
Years Active: 2025
Title: Dieter Wolfgang Hamprecht: Innovator in Neuromuscular and Neuroinflammatory Treatments
Introduction
Dieter Wolfgang Hamprecht is a notable inventor based in Frenchs Forest, Australia. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target neuromuscular and neuroinflammatory diseases.
Latest Patents
Hamprecht holds a patent for "Haloallylamine dual amine oxidase inhibitors." This invention relates to novel compounds capable of inhibiting semicarbazide-sensitive amine oxidase (SSAO/VAP-1) and monoamine oxidase B (MAO-B). These compounds are particularly useful for treating various neuromuscular diseases, such as muscular dystrophies, and neuroinflammatory diseases affecting both peripheral and central nervous systems in humans, pets, and livestock. The patent also encompasses pharmaceutical compositions containing these compounds and their various applications.
Career Highlights
Hamprecht is associated with Syntara Limited, where he continues to advance his research and development efforts. His work has the potential to significantly impact the treatment landscape for neuromuscular and neuroinflammatory conditions.
Collaborations
Hamprecht has collaborated with notable colleagues, including Alan Duncan Robertson and Alison Dorothy Findlay, contributing to a rich environment of innovation and research.
Conclusion
Dieter Wolfgang Hamprecht's work exemplifies the intersection of innovation and healthcare, particularly in addressing complex medical challenges. His contributions through patents and collaborations continue to pave the way for advancements in treatment options for various diseases.